Why is Infinium Pharma falling/rising?

As of 18-Sep, Infinium Pharmachem Ltd's stock price is currently at 249.95, reflecting a decline of 6.05, or 2.36%. The stock has underperformed its sector today by 3.41%, and it is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Additionally, there has been a notable decrease in investor participation, with delivery volume dropping by 37.5% compared to the 5-day average. Over the past week, the stock has seen a decline of 1.92%, and it has also underperformed over the past month with a decrease of 1.98%. Year-to-date, the stock is down 16.66%, contrasting sharply with the Sensex's gain of 7.52%.
In the broader market context, the Sensex has shown positive returns, gaining 1.67% over the past week and 2.20% over the past month, while Infinium Pharmachem Ltd has been on a downward trajectory. This stark contrast indicates that the stock is not only struggling in the short term but also lagging significantly behind the benchmark. The lack of positive factors in the dashboard further emphasizes the challenges facing the company, contributing to the overall negative sentiment surrounding its stock performance.